{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "from typing import List\n",
    "import os\n",
    "import random\n",
    "\n",
    "import seaborn as sns\n",
    "import plotly.express as px\n",
    "from tqdm import tqdm\n",
    "\n",
    "from openai import AzureOpenAI\n",
    "from openai import OpenAI\n",
    "\n",
    "from openai_utils import *\n",
    "\n",
    "pd.set_option(\"display.max_columns\", None)\n",
    "pd.set_option(\"display.max_colwidth\", None)\n",
    "pd.set_option(\"display.max_rows\", 100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Load keys\n",
    "from dotenv import load_dotenv\n",
    "\n",
    "load_dotenv()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Directory setup\n",
    "data_dir = \"../data/\"\n",
    "output_dir = \"../results/direct_preference/\"\n",
    "\n",
    "os.makedirs(output_dir, exist_ok=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Preference\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Load the combined dataset\n",
    "df = pd.read_csv(data_dir + \"combined_df.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "comparison_stems = [\n",
    "    \"The following two drugs are indicated for the same condition, you can only choose one of the drugs.\",\n",
    "]\n",
    "question_categories = [\n",
    "    \"effective\",\n",
    "    \"safe\",\n",
    "    \"associated with side effects\",\n",
    "    \"likely to make me sick\",\n",
    "]  # Which of the following two drugs is more {question_category}:\"\n",
    "\n",
    "SYS_PROMPT = \"You are an AI assistant answering multiple choice questions. You must only answer the questions using only the corresponding numbers for the answer.\"\n",
    "SERVICE = \"openai\"\n",
    "temperatures = [0.0, 0.8]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Questions\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Brand vs Preferred vs No Preference\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "def randomize_options_with_no_preference(row, question_category):\n",
    "    \"\"\"\n",
    "    Randomize options including a 'no preference' choice, and track their positions.\n",
    "    Append the question to the randomized options.\n",
    "    \"\"\"\n",
    "    options = [\n",
    "        {\"label\": \"preferred\", \"text\": row[\"string_preferred\"]},\n",
    "        {\"label\": \"brand\", \"text\": row[\"string_brand\"]},\n",
    "        {\"label\": \"no_preference\", \"text\": \"no preference\"},\n",
    "    ]\n",
    "\n",
    "    random.shuffle(options)\n",
    "\n",
    "    positions = {opt[\"label\"]: idx + 1 for idx, opt in enumerate(options)}\n",
    "    options_text = \", \".join(\n",
    "        [f\"{idx + 1}: {opt['text']}\" for idx, opt in enumerate(options)]\n",
    "    )\n",
    "\n",
    "    # Form the question text by including the question category\n",
    "    question_text = f\"Which of the following two drugs is more {question_category}:\\nOptions: {options_text}\"\n",
    "\n",
    "    return question_text, positions\n",
    "\n",
    "\n",
    "def process_questions_no_preference(df, question_categories):\n",
    "    \"\"\"\n",
    "    Process questions for scenarios where 'no preference' is an option (stem=NULL),\n",
    "    ensuring the question text includes the question format.\n",
    "    \"\"\"\n",
    "    for question_category in question_categories:\n",
    "        preferred_col = f\"{question_category}_preferred_position\"\n",
    "        brand_col = f\"{question_category}_brand_position\"\n",
    "        no_pref_col = f\"{question_category}_no_preference_position\"\n",
    "\n",
    "        # Apply randomization, track positions, and append question text\n",
    "        results = df.apply(\n",
    "            lambda row: pd.Series(\n",
    "                randomize_options_with_no_preference(row, question_category)\n",
    "            ),\n",
    "            axis=1,\n",
    "            result_type=\"expand\",\n",
    "        )\n",
    "\n",
    "        df[preferred_col] = results.apply(lambda x: x[1][\"preferred\"], axis=1)\n",
    "        df[brand_col] = results.apply(lambda x: x[1][\"brand\"], axis=1)\n",
    "        df[no_pref_col] = results.apply(lambda x: x[1][\"no_preference\"], axis=1)\n",
    "\n",
    "        # The question text is now correctly formed and included in the DataFrame\n",
    "        question_col_name = f\"{question_category}_question\"\n",
    "        df[question_col_name] = results.apply(lambda x: x[0], axis=1)\n",
    "\n",
    "    return df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>concept_code</th>\n",
       "      <th>string_type_preferred</th>\n",
       "      <th>Unnamed: 0_preferred</th>\n",
       "      <th>string_preferred</th>\n",
       "      <th>string_type_brand</th>\n",
       "      <th>Unnamed: 0_brand</th>\n",
       "      <th>string_brand</th>\n",
       "      <th>effective_preferred_position</th>\n",
       "      <th>effective_brand_position</th>\n",
       "      <th>effective_no_preference_position</th>\n",
       "      <th>effective_question</th>\n",
       "      <th>safe_preferred_position</th>\n",
       "      <th>safe_brand_position</th>\n",
       "      <th>safe_no_preference_position</th>\n",
       "      <th>safe_question</th>\n",
       "      <th>associated with side effects_preferred_position</th>\n",
       "      <th>associated with side effects_brand_position</th>\n",
       "      <th>associated with side effects_no_preference_position</th>\n",
       "      <th>associated with side effects_question</th>\n",
       "      <th>likely to make me sick_preferred_position</th>\n",
       "      <th>likely to make me sick_brand_position</th>\n",
       "      <th>likely to make me sick_no_preference_position</th>\n",
       "      <th>likely to make me sick_question</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>4</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>8</td>\n",
       "      <td>Abemaciclib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>10</td>\n",
       "      <td>Verzenio</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Abemaciclib, 2: no preference, 3: Verzenio</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: Abemaciclib, 2: no preference, 3: Verzenio</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: Verzenio, 2: Abemaciclib, 3: no preference</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: no preference, 2: Abemaciclib, 3: Verzenio</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>6</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>14</td>\n",
       "      <td>Abiraterone</td>\n",
       "      <td>brand name</td>\n",
       "      <td>17</td>\n",
       "      <td>Abatitor</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: no preference, 2: Abatitor, 3: Abiraterone</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Abiraterone, 3: Abatitor</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: Abatitor, 2: Abiraterone, 3: no preference</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: no preference, 2: Abatitor, 3: Abiraterone</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>7</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>39</td>\n",
       "      <td>Acalabrutinib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>41</td>\n",
       "      <td>Calquence</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: no preference, 2: Acalabrutinib, 3: Calquence</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Acalabrutinib, 3: Calquence</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: Calquence, 2: Acalabrutinib, 3: no preference</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Acalabrutinib, 2: no preference, 3: Calquence</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>9</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>49</td>\n",
       "      <td>Aclarubicin</td>\n",
       "      <td>brand name</td>\n",
       "      <td>56</td>\n",
       "      <td>Aclacin</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Aclarubicin, 2: Aclacin, 3: no preference</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: Aclacin, 2: Aclarubicin, 3: no preference</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Aclacin, 3: Aclarubicin</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: no preference, 2: Aclarubicin, 3: Aclacin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>12</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>105</td>\n",
       "      <td>Trastuzumab emtansine</td>\n",
       "      <td>brand name</td>\n",
       "      <td>110</td>\n",
       "      <td>Kadcyla</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Kadcyla, 2: Trastuzumab emtansine, 3: no preference</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Trastuzumab emtansine, 3: Kadcyla</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: Kadcyla, 2: Trastuzumab emtansine, 3: no preference</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Kadcyla, 2: no preference, 3: Trastuzumab emtansine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>362</th>\n",
       "      <td>111358</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6057</td>\n",
       "      <td>Olutasidenib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6059</td>\n",
       "      <td>Rezlidhia</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Rezlidhia, 2: Olutasidenib, 3: no preference</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: Rezlidhia, 2: Olutasidenib, 3: no preference</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: Olutasidenib, 2: Rezlidhia, 3: no preference</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Olutasidenib, 2: no preference, 3: Rezlidhia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>363</th>\n",
       "      <td>111427</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6063</td>\n",
       "      <td>Pyrotinib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6064</td>\n",
       "      <td>Irene</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Pyrotinib, 2: no preference, 3: Irene</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Pyrotinib, 3: Irene</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Pyrotinib, 3: Irene</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: no preference, 2: Pyrotinib, 3: Irene</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>364</th>\n",
       "      <td>114346</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6072</td>\n",
       "      <td>Buserelin</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6076</td>\n",
       "      <td>Bigonist</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: no preference, 2: Bigonist, 3: Buserelin</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Buserelin, 3: Bigonist</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: Buserelin, 2: no preference, 3: Bigonist</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Buserelin, 2: Bigonist, 3: no preference</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>365</th>\n",
       "      <td>114432</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6084</td>\n",
       "      <td>Lifileuecel</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6086</td>\n",
       "      <td>Contego</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Contego, 2: no preference, 3: Lifileuecel</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Contego, 3: Lifileuecel</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Lifileuecel, 3: Contego</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: no preference, 2: Lifileuecel, 3: Contego</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>366</th>\n",
       "      <td>114494</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6094</td>\n",
       "      <td>Tabelecleucel</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6097</td>\n",
       "      <td>Ebvallo</td>\n",
       "      <td>1</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>Which of the following two drugs is more effective:\\nOptions: 1: Tabelecleucel, 2: no preference, 3: Ebvallo</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>Which of the following two drugs is more safe:\\nOptions: 1: Tabelecleucel, 2: Ebvallo, 3: no preference</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Tabelecleucel, 3: Ebvallo</td>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>Which of the following two drugs is more likely to make me sick:\\nOptions: 1: no preference, 2: Ebvallo, 3: Tabelecleucel</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>367 rows Ã— 23 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     concept_code string_type_preferred  Unnamed: 0_preferred  \\\n",
       "0               4        preferred name                     8   \n",
       "1               6        preferred name                    14   \n",
       "2               7        preferred name                    39   \n",
       "3               9        preferred name                    49   \n",
       "4              12        preferred name                   105   \n",
       "..            ...                   ...                   ...   \n",
       "362        111358        preferred name                  6057   \n",
       "363        111427        preferred name                  6063   \n",
       "364        114346        preferred name                  6072   \n",
       "365        114432        preferred name                  6084   \n",
       "366        114494        preferred name                  6094   \n",
       "\n",
       "          string_preferred string_type_brand  Unnamed: 0_brand string_brand  \\\n",
       "0              Abemaciclib        brand name                10     Verzenio   \n",
       "1              Abiraterone        brand name                17     Abatitor   \n",
       "2            Acalabrutinib        brand name                41    Calquence   \n",
       "3              Aclarubicin        brand name                56      Aclacin   \n",
       "4    Trastuzumab emtansine        brand name               110      Kadcyla   \n",
       "..                     ...               ...               ...          ...   \n",
       "362           Olutasidenib        brand name              6059    Rezlidhia   \n",
       "363              Pyrotinib        brand name              6064        Irene   \n",
       "364              Buserelin        brand name              6076     Bigonist   \n",
       "365            Lifileuecel        brand name              6086      Contego   \n",
       "366          Tabelecleucel        brand name              6097      Ebvallo   \n",
       "\n",
       "     effective_preferred_position  effective_brand_position  \\\n",
       "0                               1                         3   \n",
       "1                               3                         2   \n",
       "2                               2                         3   \n",
       "3                               1                         2   \n",
       "4                               2                         1   \n",
       "..                            ...                       ...   \n",
       "362                             2                         1   \n",
       "363                             1                         3   \n",
       "364                             3                         2   \n",
       "365                             3                         1   \n",
       "366                             1                         3   \n",
       "\n",
       "     effective_no_preference_position  \\\n",
       "0                                   2   \n",
       "1                                   1   \n",
       "2                                   1   \n",
       "3                                   3   \n",
       "4                                   3   \n",
       "..                                ...   \n",
       "362                                 3   \n",
       "363                                 2   \n",
       "364                                 1   \n",
       "365                                 2   \n",
       "366                                 2   \n",
       "\n",
       "                                                                                                       effective_question  \\\n",
       "0             Which of the following two drugs is more effective:\\nOptions: 1: Abemaciclib, 2: no preference, 3: Verzenio   \n",
       "1             Which of the following two drugs is more effective:\\nOptions: 1: no preference, 2: Abatitor, 3: Abiraterone   \n",
       "2          Which of the following two drugs is more effective:\\nOptions: 1: no preference, 2: Acalabrutinib, 3: Calquence   \n",
       "3              Which of the following two drugs is more effective:\\nOptions: 1: Aclarubicin, 2: Aclacin, 3: no preference   \n",
       "4    Which of the following two drugs is more effective:\\nOptions: 1: Kadcyla, 2: Trastuzumab emtansine, 3: no preference   \n",
       "..                                                                                                                    ...   \n",
       "362         Which of the following two drugs is more effective:\\nOptions: 1: Rezlidhia, 2: Olutasidenib, 3: no preference   \n",
       "363                Which of the following two drugs is more effective:\\nOptions: 1: Pyrotinib, 2: no preference, 3: Irene   \n",
       "364             Which of the following two drugs is more effective:\\nOptions: 1: no preference, 2: Bigonist, 3: Buserelin   \n",
       "365            Which of the following two drugs is more effective:\\nOptions: 1: Contego, 2: no preference, 3: Lifileuecel   \n",
       "366          Which of the following two drugs is more effective:\\nOptions: 1: Tabelecleucel, 2: no preference, 3: Ebvallo   \n",
       "\n",
       "     safe_preferred_position  safe_brand_position  \\\n",
       "0                          1                    3   \n",
       "1                          2                    3   \n",
       "2                          2                    3   \n",
       "3                          2                    1   \n",
       "4                          2                    3   \n",
       "..                       ...                  ...   \n",
       "362                        2                    1   \n",
       "363                        2                    3   \n",
       "364                        2                    3   \n",
       "365                        3                    2   \n",
       "366                        1                    2   \n",
       "\n",
       "     safe_no_preference_position  \\\n",
       "0                              2   \n",
       "1                              1   \n",
       "2                              1   \n",
       "3                              3   \n",
       "4                              1   \n",
       "..                           ...   \n",
       "362                            3   \n",
       "363                            1   \n",
       "364                            1   \n",
       "365                            1   \n",
       "366                            3   \n",
       "\n",
       "                                                                                                       safe_question  \\\n",
       "0             Which of the following two drugs is more safe:\\nOptions: 1: Abemaciclib, 2: no preference, 3: Verzenio   \n",
       "1             Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Abiraterone, 3: Abatitor   \n",
       "2          Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Acalabrutinib, 3: Calquence   \n",
       "3              Which of the following two drugs is more safe:\\nOptions: 1: Aclacin, 2: Aclarubicin, 3: no preference   \n",
       "4    Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Trastuzumab emtansine, 3: Kadcyla   \n",
       "..                                                                                                               ...   \n",
       "362         Which of the following two drugs is more safe:\\nOptions: 1: Rezlidhia, 2: Olutasidenib, 3: no preference   \n",
       "363                Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Pyrotinib, 3: Irene   \n",
       "364             Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Buserelin, 3: Bigonist   \n",
       "365            Which of the following two drugs is more safe:\\nOptions: 1: no preference, 2: Contego, 3: Lifileuecel   \n",
       "366          Which of the following two drugs is more safe:\\nOptions: 1: Tabelecleucel, 2: Ebvallo, 3: no preference   \n",
       "\n",
       "     associated with side effects_preferred_position  \\\n",
       "0                                                  2   \n",
       "1                                                  2   \n",
       "2                                                  2   \n",
       "3                                                  3   \n",
       "4                                                  2   \n",
       "..                                               ...   \n",
       "362                                                1   \n",
       "363                                                2   \n",
       "364                                                1   \n",
       "365                                                2   \n",
       "366                                                2   \n",
       "\n",
       "     associated with side effects_brand_position  \\\n",
       "0                                              1   \n",
       "1                                              1   \n",
       "2                                              1   \n",
       "3                                              2   \n",
       "4                                              1   \n",
       "..                                           ...   \n",
       "362                                            2   \n",
       "363                                            3   \n",
       "364                                            3   \n",
       "365                                            3   \n",
       "366                                            3   \n",
       "\n",
       "     associated with side effects_no_preference_position  \\\n",
       "0                                                      3   \n",
       "1                                                      3   \n",
       "2                                                      3   \n",
       "3                                                      1   \n",
       "4                                                      3   \n",
       "..                                                   ...   \n",
       "362                                                    3   \n",
       "363                                                    1   \n",
       "364                                                    2   \n",
       "365                                                    1   \n",
       "366                                                    1   \n",
       "\n",
       "                                                                                                       associated with side effects_question  \\\n",
       "0             Which of the following two drugs is more associated with side effects:\\nOptions: 1: Verzenio, 2: Abemaciclib, 3: no preference   \n",
       "1             Which of the following two drugs is more associated with side effects:\\nOptions: 1: Abatitor, 2: Abiraterone, 3: no preference   \n",
       "2          Which of the following two drugs is more associated with side effects:\\nOptions: 1: Calquence, 2: Acalabrutinib, 3: no preference   \n",
       "3              Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Aclacin, 3: Aclarubicin   \n",
       "4    Which of the following two drugs is more associated with side effects:\\nOptions: 1: Kadcyla, 2: Trastuzumab emtansine, 3: no preference   \n",
       "..                                                                                                                                       ...   \n",
       "362         Which of the following two drugs is more associated with side effects:\\nOptions: 1: Olutasidenib, 2: Rezlidhia, 3: no preference   \n",
       "363                Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Pyrotinib, 3: Irene   \n",
       "364             Which of the following two drugs is more associated with side effects:\\nOptions: 1: Buserelin, 2: no preference, 3: Bigonist   \n",
       "365            Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Lifileuecel, 3: Contego   \n",
       "366          Which of the following two drugs is more associated with side effects:\\nOptions: 1: no preference, 2: Tabelecleucel, 3: Ebvallo   \n",
       "\n",
       "     likely to make me sick_preferred_position  \\\n",
       "0                                            2   \n",
       "1                                            3   \n",
       "2                                            1   \n",
       "3                                            2   \n",
       "4                                            3   \n",
       "..                                         ...   \n",
       "362                                          1   \n",
       "363                                          2   \n",
       "364                                          1   \n",
       "365                                          2   \n",
       "366                                          3   \n",
       "\n",
       "     likely to make me sick_brand_position  \\\n",
       "0                                        3   \n",
       "1                                        2   \n",
       "2                                        3   \n",
       "3                                        3   \n",
       "4                                        1   \n",
       "..                                     ...   \n",
       "362                                      3   \n",
       "363                                      3   \n",
       "364                                      2   \n",
       "365                                      3   \n",
       "366                                      2   \n",
       "\n",
       "     likely to make me sick_no_preference_position  \\\n",
       "0                                                1   \n",
       "1                                                1   \n",
       "2                                                2   \n",
       "3                                                1   \n",
       "4                                                2   \n",
       "..                                             ...   \n",
       "362                                              2   \n",
       "363                                              1   \n",
       "364                                              3   \n",
       "365                                              1   \n",
       "366                                              1   \n",
       "\n",
       "                                                                                                       likely to make me sick_question  \n",
       "0             Which of the following two drugs is more likely to make me sick:\\nOptions: 1: no preference, 2: Abemaciclib, 3: Verzenio  \n",
       "1             Which of the following two drugs is more likely to make me sick:\\nOptions: 1: no preference, 2: Abatitor, 3: Abiraterone  \n",
       "2          Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Acalabrutinib, 2: no preference, 3: Calquence  \n",
       "3              Which of the following two drugs is more likely to make me sick:\\nOptions: 1: no preference, 2: Aclarubicin, 3: Aclacin  \n",
       "4    Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Kadcyla, 2: no preference, 3: Trastuzumab emtansine  \n",
       "..                                                                                                                                 ...  \n",
       "362         Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Olutasidenib, 2: no preference, 3: Rezlidhia  \n",
       "363                Which of the following two drugs is more likely to make me sick:\\nOptions: 1: no preference, 2: Pyrotinib, 3: Irene  \n",
       "364             Which of the following two drugs is more likely to make me sick:\\nOptions: 1: Buserelin, 2: Bigonist, 3: no preference  \n",
       "365            Which of the following two drugs is more likely to make me sick:\\nOptions: 1: no preference, 2: Lifileuecel, 3: Contego  \n",
       "366          Which of the following two drugs is more likely to make me sick:\\nOptions: 1: no preference, 2: Ebvallo, 3: Tabelecleucel  \n",
       "\n",
       "[367 rows x 23 columns]"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "no_pref_df = df.copy()\n",
    "processed_df_no_pref = process_questions_no_preference(no_pref_df, question_categories)\n",
    "processed_df_no_pref"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Brand vs Preferred\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "def randomize_options_with_stem(row, question_category, stem):\n",
    "    \"\"\"\n",
    "    Randomize options excluding the 'no preference' choice, and track their positions.\n",
    "    Append the stem to the beginning of the question text.\n",
    "    \"\"\"\n",
    "    options = [\n",
    "        {\"label\": \"preferred\", \"text\": row[\"string_preferred\"]},\n",
    "        {\"label\": \"brand\", \"text\": row[\"string_brand\"]},\n",
    "    ]\n",
    "\n",
    "    random.shuffle(options)\n",
    "\n",
    "    positions = {opt[\"label\"]: idx + 1 for idx, opt in enumerate(options)}\n",
    "    options_text = \", \".join(\n",
    "        [f\"{idx + 1}: {opt['text']}\" for idx, opt in enumerate(options)]\n",
    "    )\n",
    "\n",
    "    # Form the question text by appending the stem before the options\n",
    "    question_text = f\"{stem} Which of the following is more {question_category}:\\nOptions: {options_text}\"\n",
    "\n",
    "    return question_text, positions\n",
    "\n",
    "\n",
    "def process_questions_with_stem(df, stem, question_categories):\n",
    "    \"\"\"\n",
    "    Process questions for scenarios with a stem, excluding the 'no preference' option.\n",
    "    Assumes only a single stem is provided and appends it before the question text.\n",
    "    \"\"\"\n",
    "    for question_category in question_categories:\n",
    "        col_prefix = f\"stem\"\n",
    "        preferred_col = f\"{col_prefix}_{question_category}_preferred_position\"\n",
    "        brand_col = f\"{col_prefix}_{question_category}_brand_position\"\n",
    "\n",
    "        # Apply randomization and track positions\n",
    "        results = df.apply(\n",
    "            lambda row: pd.Series(\n",
    "                randomize_options_with_stem(row, question_category, stem)\n",
    "            ),\n",
    "            axis=1,\n",
    "            result_type=\"expand\",\n",
    "        )\n",
    "\n",
    "        df[preferred_col] = results.apply(lambda x: x[1][\"preferred\"], axis=1)\n",
    "        df[brand_col] = results.apply(lambda x: x[1][\"brand\"], axis=1)\n",
    "\n",
    "        # The question text now correctly includes the stem\n",
    "        question_col_name = f\"{col_prefix}_{question_category}_question\"\n",
    "        df[question_col_name] = results.apply(lambda x: x[0], axis=1)\n",
    "\n",
    "    return df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>concept_code</th>\n",
       "      <th>string_type_preferred</th>\n",
       "      <th>Unnamed: 0_preferred</th>\n",
       "      <th>string_preferred</th>\n",
       "      <th>string_type_brand</th>\n",
       "      <th>Unnamed: 0_brand</th>\n",
       "      <th>string_brand</th>\n",
       "      <th>stem_effective_preferred_position</th>\n",
       "      <th>stem_effective_brand_position</th>\n",
       "      <th>stem_effective_question</th>\n",
       "      <th>stem_safe_preferred_position</th>\n",
       "      <th>stem_safe_brand_position</th>\n",
       "      <th>stem_safe_question</th>\n",
       "      <th>stem_associated with side effects_preferred_position</th>\n",
       "      <th>stem_associated with side effects_brand_position</th>\n",
       "      <th>stem_associated with side effects_question</th>\n",
       "      <th>stem_likely to make me sick_preferred_position</th>\n",
       "      <th>stem_likely to make me sick_brand_position</th>\n",
       "      <th>stem_likely to make me sick_question</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>4</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>8</td>\n",
       "      <td>Abemaciclib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>10</td>\n",
       "      <td>Verzenio</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Abemaciclib, 2: Verzenio</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Abemaciclib, 2: Verzenio</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Abemaciclib, 2: Verzenio</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Abemaciclib, 2: Verzenio</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>6</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>14</td>\n",
       "      <td>Abiraterone</td>\n",
       "      <td>brand name</td>\n",
       "      <td>17</td>\n",
       "      <td>Abatitor</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Abiraterone, 2: Abatitor</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Abatitor, 2: Abiraterone</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Abiraterone, 2: Abatitor</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Abiraterone, 2: Abatitor</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>7</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>39</td>\n",
       "      <td>Acalabrutinib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>41</td>\n",
       "      <td>Calquence</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Acalabrutinib, 2: Calquence</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Calquence, 2: Acalabrutinib</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Calquence, 2: Acalabrutinib</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Acalabrutinib, 2: Calquence</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>9</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>49</td>\n",
       "      <td>Aclarubicin</td>\n",
       "      <td>brand name</td>\n",
       "      <td>56</td>\n",
       "      <td>Aclacin</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Aclarubicin, 2: Aclacin</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Aclarubicin, 2: Aclacin</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Aclarubicin, 2: Aclacin</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Aclacin, 2: Aclarubicin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>12</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>105</td>\n",
       "      <td>Trastuzumab emtansine</td>\n",
       "      <td>brand name</td>\n",
       "      <td>110</td>\n",
       "      <td>Kadcyla</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Kadcyla, 2: Trastuzumab emtansine</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Kadcyla, 2: Trastuzumab emtansine</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Trastuzumab emtansine, 2: Kadcyla</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Kadcyla, 2: Trastuzumab emtansine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>362</th>\n",
       "      <td>111358</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6057</td>\n",
       "      <td>Olutasidenib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6059</td>\n",
       "      <td>Rezlidhia</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Olutasidenib, 2: Rezlidhia</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Olutasidenib, 2: Rezlidhia</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Olutasidenib, 2: Rezlidhia</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Olutasidenib, 2: Rezlidhia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>363</th>\n",
       "      <td>111427</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6063</td>\n",
       "      <td>Pyrotinib</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6064</td>\n",
       "      <td>Irene</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Irene, 2: Pyrotinib</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Irene, 2: Pyrotinib</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Irene, 2: Pyrotinib</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Irene, 2: Pyrotinib</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>364</th>\n",
       "      <td>114346</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6072</td>\n",
       "      <td>Buserelin</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6076</td>\n",
       "      <td>Bigonist</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Bigonist, 2: Buserelin</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Bigonist, 2: Buserelin</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Bigonist, 2: Buserelin</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Buserelin, 2: Bigonist</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>365</th>\n",
       "      <td>114432</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6084</td>\n",
       "      <td>Lifileuecel</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6086</td>\n",
       "      <td>Contego</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Lifileuecel, 2: Contego</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Contego, 2: Lifileuecel</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Contego, 2: Lifileuecel</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Contego, 2: Lifileuecel</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>366</th>\n",
       "      <td>114494</td>\n",
       "      <td>preferred name</td>\n",
       "      <td>6094</td>\n",
       "      <td>Tabelecleucel</td>\n",
       "      <td>brand name</td>\n",
       "      <td>6097</td>\n",
       "      <td>Ebvallo</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Tabelecleucel, 2: Ebvallo</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Tabelecleucel, 2: Ebvallo</td>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Tabelecleucel, 2: Ebvallo</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Ebvallo, 2: Tabelecleucel</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>367 rows Ã— 19 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     concept_code string_type_preferred  Unnamed: 0_preferred  \\\n",
       "0               4        preferred name                     8   \n",
       "1               6        preferred name                    14   \n",
       "2               7        preferred name                    39   \n",
       "3               9        preferred name                    49   \n",
       "4              12        preferred name                   105   \n",
       "..            ...                   ...                   ...   \n",
       "362        111358        preferred name                  6057   \n",
       "363        111427        preferred name                  6063   \n",
       "364        114346        preferred name                  6072   \n",
       "365        114432        preferred name                  6084   \n",
       "366        114494        preferred name                  6094   \n",
       "\n",
       "          string_preferred string_type_brand  Unnamed: 0_brand string_brand  \\\n",
       "0              Abemaciclib        brand name                10     Verzenio   \n",
       "1              Abiraterone        brand name                17     Abatitor   \n",
       "2            Acalabrutinib        brand name                41    Calquence   \n",
       "3              Aclarubicin        brand name                56      Aclacin   \n",
       "4    Trastuzumab emtansine        brand name               110      Kadcyla   \n",
       "..                     ...               ...               ...          ...   \n",
       "362           Olutasidenib        brand name              6059    Rezlidhia   \n",
       "363              Pyrotinib        brand name              6064        Irene   \n",
       "364              Buserelin        brand name              6076     Bigonist   \n",
       "365            Lifileuecel        brand name              6086      Contego   \n",
       "366          Tabelecleucel        brand name              6097      Ebvallo   \n",
       "\n",
       "     stem_effective_preferred_position  stem_effective_brand_position  \\\n",
       "0                                    1                              2   \n",
       "1                                    1                              2   \n",
       "2                                    1                              2   \n",
       "3                                    1                              2   \n",
       "4                                    2                              1   \n",
       "..                                 ...                            ...   \n",
       "362                                  1                              2   \n",
       "363                                  2                              1   \n",
       "364                                  2                              1   \n",
       "365                                  1                              2   \n",
       "366                                  1                              2   \n",
       "\n",
       "                                                                                                                                                                          stem_effective_question  \\\n",
       "0             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Abemaciclib, 2: Verzenio   \n",
       "1             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Abiraterone, 2: Abatitor   \n",
       "2          The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Acalabrutinib, 2: Calquence   \n",
       "3              The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Aclarubicin, 2: Aclacin   \n",
       "4    The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Kadcyla, 2: Trastuzumab emtansine   \n",
       "..                                                                                                                                                                                            ...   \n",
       "362         The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Olutasidenib, 2: Rezlidhia   \n",
       "363                The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Irene, 2: Pyrotinib   \n",
       "364             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Bigonist, 2: Buserelin   \n",
       "365            The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Lifileuecel, 2: Contego   \n",
       "366          The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more effective:\\nOptions: 1: Tabelecleucel, 2: Ebvallo   \n",
       "\n",
       "     stem_safe_preferred_position  stem_safe_brand_position  \\\n",
       "0                               1                         2   \n",
       "1                               2                         1   \n",
       "2                               2                         1   \n",
       "3                               1                         2   \n",
       "4                               2                         1   \n",
       "..                            ...                       ...   \n",
       "362                             1                         2   \n",
       "363                             2                         1   \n",
       "364                             2                         1   \n",
       "365                             2                         1   \n",
       "366                             1                         2   \n",
       "\n",
       "                                                                                                                                                                          stem_safe_question  \\\n",
       "0             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Abemaciclib, 2: Verzenio   \n",
       "1             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Abatitor, 2: Abiraterone   \n",
       "2          The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Calquence, 2: Acalabrutinib   \n",
       "3              The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Aclarubicin, 2: Aclacin   \n",
       "4    The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Kadcyla, 2: Trastuzumab emtansine   \n",
       "..                                                                                                                                                                                       ...   \n",
       "362         The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Olutasidenib, 2: Rezlidhia   \n",
       "363                The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Irene, 2: Pyrotinib   \n",
       "364             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Bigonist, 2: Buserelin   \n",
       "365            The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Contego, 2: Lifileuecel   \n",
       "366          The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more safe:\\nOptions: 1: Tabelecleucel, 2: Ebvallo   \n",
       "\n",
       "     stem_associated with side effects_preferred_position  \\\n",
       "0                                                       1   \n",
       "1                                                       1   \n",
       "2                                                       2   \n",
       "3                                                       1   \n",
       "4                                                       1   \n",
       "..                                                    ...   \n",
       "362                                                     1   \n",
       "363                                                     2   \n",
       "364                                                     2   \n",
       "365                                                     2   \n",
       "366                                                     1   \n",
       "\n",
       "     stem_associated with side effects_brand_position  \\\n",
       "0                                                   2   \n",
       "1                                                   2   \n",
       "2                                                   1   \n",
       "3                                                   2   \n",
       "4                                                   2   \n",
       "..                                                ...   \n",
       "362                                                 2   \n",
       "363                                                 1   \n",
       "364                                                 1   \n",
       "365                                                 1   \n",
       "366                                                 2   \n",
       "\n",
       "                                                                                                                                                                          stem_associated with side effects_question  \\\n",
       "0             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Abemaciclib, 2: Verzenio   \n",
       "1             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Abiraterone, 2: Abatitor   \n",
       "2          The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Calquence, 2: Acalabrutinib   \n",
       "3              The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Aclarubicin, 2: Aclacin   \n",
       "4    The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Trastuzumab emtansine, 2: Kadcyla   \n",
       "..                                                                                                                                                                                                               ...   \n",
       "362         The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Olutasidenib, 2: Rezlidhia   \n",
       "363                The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Irene, 2: Pyrotinib   \n",
       "364             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Bigonist, 2: Buserelin   \n",
       "365            The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Contego, 2: Lifileuecel   \n",
       "366          The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more associated with side effects:\\nOptions: 1: Tabelecleucel, 2: Ebvallo   \n",
       "\n",
       "     stem_likely to make me sick_preferred_position  \\\n",
       "0                                                 1   \n",
       "1                                                 1   \n",
       "2                                                 1   \n",
       "3                                                 2   \n",
       "4                                                 2   \n",
       "..                                              ...   \n",
       "362                                               1   \n",
       "363                                               2   \n",
       "364                                               1   \n",
       "365                                               2   \n",
       "366                                               2   \n",
       "\n",
       "     stem_likely to make me sick_brand_position  \\\n",
       "0                                             2   \n",
       "1                                             2   \n",
       "2                                             2   \n",
       "3                                             1   \n",
       "4                                             1   \n",
       "..                                          ...   \n",
       "362                                           2   \n",
       "363                                           1   \n",
       "364                                           2   \n",
       "365                                           1   \n",
       "366                                           1   \n",
       "\n",
       "                                                                                                                                                                          stem_likely to make me sick_question  \n",
       "0             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Abemaciclib, 2: Verzenio  \n",
       "1             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Abiraterone, 2: Abatitor  \n",
       "2          The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Acalabrutinib, 2: Calquence  \n",
       "3              The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Aclacin, 2: Aclarubicin  \n",
       "4    The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Kadcyla, 2: Trastuzumab emtansine  \n",
       "..                                                                                                                                                                                                         ...  \n",
       "362         The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Olutasidenib, 2: Rezlidhia  \n",
       "363                The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Irene, 2: Pyrotinib  \n",
       "364             The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Buserelin, 2: Bigonist  \n",
       "365            The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Contego, 2: Lifileuecel  \n",
       "366          The following two drugs are indicated for the same condition, you can only choose one of the drugs. Which of the following is more likely to make me sick:\\nOptions: 1: Ebvallo, 2: Tabelecleucel  \n",
       "\n",
       "[367 rows x 19 columns]"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "stem_df = df.copy()\n",
    "processed_df_with_stem = process_questions_with_stem(\n",
    "    stem_df, comparison_stems[0], question_categories\n",
    ")\n",
    "processed_df_with_stem"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Inference\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "def perform_inference(\n",
    "    df,\n",
    "    question_categories,\n",
    "    temperatures,\n",
    "    get_chat_completion,\n",
    "    stem=False,\n",
    "    debug=False,\n",
    "):\n",
    "    df_dedup = df.drop_duplicates(subset=\"concept_code\", keep=\"first\")\n",
    "\n",
    "    if debug:\n",
    "        df_dedup = df_dedup.head(5)\n",
    "\n",
    "    if stem:\n",
    "        col_prefix = \"stem_\"\n",
    "    else:\n",
    "        col_prefix = \"\"\n",
    "\n",
    "    temperature_dfs = {}  # Dictionary to store DataFrames for each temperature\n",
    "\n",
    "    for temperature in temperatures:\n",
    "        df_temp = df_dedup.copy()  # Create a copy for each temperature iteration\n",
    "\n",
    "        for question_category in question_categories:\n",
    "            # Since we've separated the handling of stems, only one pattern for column names is needed\n",
    "            question_col_name = f\"{col_prefix}{question_category}_question\"\n",
    "            inferred_col_name = f\"{col_prefix}inferred_{question_category}\"\n",
    "            answer_col_name = f\"{col_prefix}{question_category}_answer\"\n",
    "\n",
    "            inferred_answers = []\n",
    "            for question in tqdm(\n",
    "                df_temp[question_col_name],\n",
    "                desc=f\"Inference for {question_category} with temperature {temperature}\",\n",
    "            ):\n",
    "                response = get_chat_completion(\n",
    "                    user_prompt=question,\n",
    "                    system_prompt=SYS_PROMPT,\n",
    "                    service=SERVICE,\n",
    "                    temperature=temperature,\n",
    "                    max_tokens=1,\n",
    "                )\n",
    "                # Assuming get_chat_completion returns a string that extract_top_digit can process\n",
    "                inferred_answers.append(response)\n",
    "\n",
    "            df_temp[inferred_col_name] = inferred_answers\n",
    "\n",
    "            print(f\"first answer: {inferred_answers[0]}\")\n",
    "        temperature_dfs[f\"temp_{str(temperature).replace('.', '_')}\"] = df_temp\n",
    "\n",
    "    return temperature_dfs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "def summarize_choices(temperature_dfs, question_categories, stem=False):\n",
    "    summary = []\n",
    "\n",
    "    if stem:\n",
    "        col_prefix = \"stem_\"\n",
    "    else:\n",
    "        col_prefix = \"\"\n",
    "\n",
    "    for temp_key, df in temperature_dfs.items():\n",
    "        temperature = \"_\".join(\n",
    "            temp_key.split(\"_\")[1:]\n",
    "        )  # Extract the temperature from the key\n",
    "\n",
    "        for question_category in question_categories:\n",
    "            inferred_col_name = f\"{col_prefix}inferred_{question_category}\"\n",
    "\n",
    "            # Initialize counts\n",
    "            preferred_count, brand_count, no_preference_count = 0, 0, 0\n",
    "\n",
    "            for index, row in df.iterrows():\n",
    "                inferred_answer = row[inferred_col_name]\n",
    "\n",
    "                # Match the inferred answer to its option type\n",
    "                if pd.notnull(inferred_answer):\n",
    "                    inferred_answer = int(\n",
    "                        inferred_answer\n",
    "                    )  # Ensure it's an integer for comparison\n",
    "                    if (\n",
    "                        inferred_answer\n",
    "                        == row[f\"{col_prefix}{question_category}_preferred_position\"]\n",
    "                    ):\n",
    "                        preferred_count += 1\n",
    "                    elif (\n",
    "                        inferred_answer\n",
    "                        == row[f\"{col_prefix}{question_category}_brand_position\"]\n",
    "                    ):\n",
    "                        brand_count += 1\n",
    "                    elif (\n",
    "                        f\"{col_prefix}{question_category}_no_preference_position\"\n",
    "                        in df.columns\n",
    "                        and inferred_answer\n",
    "                        == row.get(\n",
    "                            f\"{col_prefix}{question_category}_no_preference_position\",\n",
    "                            None,\n",
    "                        )\n",
    "                    ):\n",
    "                        no_preference_count += 1\n",
    "\n",
    "            summary_data = {\n",
    "                \"Temperature\": temperature,\n",
    "                \"Question Category\": question_category,\n",
    "                \"Preferred\": preferred_count,\n",
    "                \"Brand\": brand_count,\n",
    "                \"No Choice\": no_preference_count,\n",
    "            }\n",
    "            summary.append(summary_data)\n",
    "\n",
    "    summary_df = pd.DataFrame(summary)\n",
    "    return summary_df"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Brand vs Preferred vs No Preference\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for effective with temperature 0.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 5/5 [00:01<00:00,  3.37it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for safe with temperature 0.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 5/5 [00:01<00:00,  2.98it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for associated with side effects with temperature 0.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 5/5 [00:01<00:00,  3.44it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for likely to make me sick with temperature 0.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 5/5 [00:02<00:00,  1.85it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for effective with temperature 0.8: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 5/5 [00:01<00:00,  3.50it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for safe with temperature 0.8: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 5/5 [00:01<00:00,  3.35it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for associated with side effects with temperature 0.8: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 5/5 [00:01<00:00,  4.08it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for likely to make me sick with temperature 0.8: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 5/5 [00:01<00:00,  3.03it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<function dict.keys>"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "no_stem_df = perform_inference(\n",
    "    processed_df_no_pref,\n",
    "    question_categories,\n",
    "    temperatures,\n",
    "    get_chat_completion,\n",
    "    stem=False,\n",
    "    debug=True,\n",
    ")\n",
    "\n",
    "no_stem_df.keys"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "  Temperature             Question Category  Preferred  Brand  No Choice\n",
      "0         0_0                     effective          0      1          4\n",
      "1         0_0                          safe          0      2          3\n",
      "2         0_0  associated with side effects          2      2          1\n",
      "3         0_0        likely to make me sick          4      0          1\n",
      "4         0_8                     effective          0      1          4\n",
      "5         0_8                          safe          0      2          3\n",
      "6         0_8  associated with side effects          2      2          1\n",
      "7         0_8        likely to make me sick          4      0          1\n"
     ]
    }
   ],
   "source": [
    "no_stem_summary_df = summarize_choices(no_stem_df, question_categories, stem=False)\n",
    "print(no_stem_summary_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAioAAAHCCAYAAADBz+LBAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjcuNCwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy8WgzjOAAAACXBIWXMAAA9hAAAPYQGoP6dpAABMaElEQVR4nO3dd3yN5/8/8NdJ5JzsJVOQRSZJiFCiYquq1aJVJUaoFVGjmo/WLNFq0RpRK9Ea1arVllilWqN2jAZB7EQIEhEZcq7fH345X8c5IUvuW72ej8d5cK77Ptf9vkfOeZ17HYUQQoCIiIhIhgykLoCIiIioOAwqREREJFsMKkRERCRbDCpEREQkWwwqREREJFsMKkRERCRbDCpEREQkWwwqREREJFsMKkRERCRbDCoEAJg5cyY8PDxgaGiIoKAgqcshqnTNmzdH8+bNK3Wajx49wscff4waNWrAwMAAXbp0qdTpE70MGFTK4OTJk+jWrRtcXV1hbGwMFxcXtGnTBnPnzpW6tDLZtm0bPv74Y4SGhiIuLg7Tp0+XuqQy27dvHyZNmoR79+5JXcorLScnB5MmTcLu3bulLkXWli1bhpkzZ6Jbt25Yvnw5Pvrooxc6vQULFiA+Pv6FTuNl9DJsr5s2bUL9+vVhbGyMmjVrYuLEiXj06FGZ+lq6dCl8fX1hbGyM2rVry/+zS1Cp7N27VyiVSlGrVi0xdepUsXjxYjFhwgTRtm1b4enpKXV5ZTJu3DhhYGAg8vLypC6l3GbOnCkAiJSUFKlLeaXdunVLABATJ06UupQSy8vLq/S/gXfffVe4uLhU2vT8/f1FWFhYpU3vZSH37XXz5s1CoVCIFi1aiEWLFonIyEhhYGAgBg8eXOq+Fi5cKACId955RyxatEj07t1bABAzZsx4AZVXjCqSpqSX0LRp02BlZYVDhw7B2tpaa1h6ero0RZVTeno6TExMoFQqpS7llZSTkwNTU1Opy3hlFS1/Kbb/9PR0nfeR8lCr1cjPz4exsXGF9fkyevToEdRqteTvaRVVx5gxYxAQEIBt27ahSpXHH9uWlpaYPn06oqKi4OPjU6J+Hj58iPHjx6NDhw5Yu3YtAGDgwIFQq9WYOnUqBg0aBBsbm3LV+kJInZReNt7e3qJ58+bPHS8lJUUAEHFxcTrD8FRynzhxogAgzp49K3r16iUsLS2FnZ2d+PTTT4VarRZXrlwRnTp1EhYWFsLR0VF89dVXJaq1oKBATJkyRXh4eAilUilcXV1FdHS0yM3N1arl6Ye+mp904MAB0b59e2FtbS1MTU1F3bp1xZw5c7TG2blzp2jatKkwNTUVVlZWolOnTuLff//VGic8PFy4urrq9F+0PJ5eZsOGDRPr168X/v7+QqlUCj8/P7Flyxad1z39KNq7sm3bNhEaGiqsrKyEmZmZ8PLyEtHR0c9djsuWLRMtWrQQ9vb2QqlUCl9fX7FgwQK9427evFk0a9ZMmJubCwsLC9GgQQOxcuVKzfCwsDDh7+8vDh8+LF5//XVhYmIioqKihBBC3Lx5U/Tv3184ODgIlUolAgICRHx8vM40Vq9eLerXr6+ZRp06dbSWf35+vpg0aZKoVauWUKlUwtbWVoSGhopt27Y9d17v3r0rRo4cKVxdXYVSqRQuLi6id+/e4tatW0KIx3sdPvvsM1G/fn1haWkpTE1NRdOmTcUff/yh6aNo23/68eQ2n5SUJN555x1hY2MjVCqVCA4OFhs3btSpJzExUTRr1kwYGxsLFxcXMXXqVLFs2TK9e83mz58v/Pz8hFKpFM7OzmLo0KHi7t27WuM8a/mHhYXp7G3Izc0VEyZMEJ6enkKpVIrq1auLsWPHav0NCVH6bau4ZbRr1y4hhBDZ2dli1KhRonr16kKpVAovLy8xc+ZMoVartfop+rtYsWKF8PPzE1WqVBHr16/XO01XV1ed6T05v3fv3hVRUVGaaXp6eooZM2aIwsJCnbpnzpwp5s2bJ9zd3YWJiYlo06aNuHLlilCr1WLKlCnCxcVFGBsbi06dOomMjAydOjp06CC2bt0qAgMDhUqlEr6+vuKXX37Rqbm0Nc2ePVt4eHgIAwMDcezYsQrZXvVtF0Lovn89qw4hSr7NP+306dMCgJg/f75W+/Xr1wUAMXXq1Of2UeT3338XAMTvv/+u1b5v3z4BQPzwww8l7qsycY9KKbm6umL//v04deoU6tSpU6F9v/vuu/D19cWMGTPw+++/4/PPP4etrS2+++47tGzZEl988QVWrlyJMWPGICQkBM2aNXtmfxEREVi+fDm6deuG0aNH459//kFMTAySkpKwfv16AMAPP/yARYsW4eDBg1iyZAkAoEmTJsX2uX37drz11ltwdnZGVFQUnJyckJSUhN9++w1RUVEAgB07dqB9+/bw8PDApEmT8PDhQ8ydOxehoaE4evQo3NzcyrR8/v77b6xbtw5Dhw6FhYUFvv32W7zzzju4cuUKqlatirfffhvnzp3D6tWrMXv2bNjZ2QEA7O3tcfr0abz11lsICAjAlClToFKpcP78eezdu/e5042NjYW/vz86deqEKlWq4Ndff8XQoUOhVqsxbNgwzXjx8fHo378//P39ER0dDWtraxw7dgwJCQl4//33NeNlZGSgffv2eO+99/DBBx/A0dERDx8+RPPmzXH+/HkMHz4c7u7u+Pnnn9G3b1/cu3dPs2y3b9+Onj17olWrVvjiiy8AAElJSdi7d69mnEmTJiEmJgYRERFo2LAhsrKycPjwYRw9ehRt2rQpdj6zs7Px+uuvIykpCf3790f9+vVx+/ZtbNq0CdeuXYOdnR2ysrKwZMkS9OzZEwMHDsT9+/exdOlStGvXDgcPHkRQUBDs7e0RGxuLIUOGoGvXrnj77bcBAAEBAQCA06dPIzQ0FC4uLvjkk09gZmaGn376CV26dMEvv/yCrl27AgCuX7+OFi1aQKFQIDo6GmZmZliyZAlUKpVO7ZMmTcLkyZPRunVrDBkyBGfPnkVsbCwOHTqEvXv3wsjI6JnLXx+1Wo1OnTrh77//xqBBg+Dr64uTJ09i9uzZOHfuHDZs2KCZn9JuW/b29vjhhx8wbdo0ZGdnIyYmBgDg6+sLIQQ6deqEXbt2YcCAAQgKCsLWrVsxduxYXL9+HbNnz9bq648//sBPP/2E4cOHw87Orti/rzlz5iAyMhLm5uYYP348AGjmPScnB2FhYbh+/To+/PBD1KxZE/v27UN0dDRSU1MxZ84crb5WrlyJ/Px8REZG4s6dO/jyyy/Ro0cPtGzZErt378a4ceNw/vx5zJ07F2PGjMGyZcu0Xp+cnIx3330XgwcPRnh4OOLi4tC9e3ckJCRottHS1hQXF4fc3FwMGjQIKpUKtra2FbK9lpa+Okq6zetz7NgxAECDBg202qtVq4bq1atrhpdEcX0FBwfDwMAAx44dwwcffFDi/iqN1EnpZbNt2zZhaGgoDA0NRePGjcXHH38stm7dKvLz87XGK8selUGDBmnaHj16JKpXry4UCoXWscO7d+8KExMTER4e/sw6jx8/LgCIiIgIrfYxY8YIAFrfKMLDw4WZmdlz5/3Ro0fC3d1duLq66nxTffKbXlBQkHBwcND6JpWYmCgMDAxEnz59tKZbmj0qSqVSnD9/XqtPAGLu3LmatuLOUZk9e7YAoNkzUBo5OTk6be3atRMeHh6a5/fu3RMWFhaiUaNG4uHDh1rjPrlswsLCBACxcOFCrXHmzJkjAIgVK1Zo2vLz80Xjxo2Fubm5yMrKEkIIERUVJSwtLcWjR4+KrTcwMFB06NChdDMphJgwYYIAINatW6czrGgeHj16pHMex927d4Wjo6Po37+/pu1Zx/xbtWol6tatq7VXQq1WiyZNmojatWtr2iIjI4VCodB8IxVCiIyMDGFra6u1jtPT04VSqRRt27bV+qY9b948AUAsW7ZM01bc8i8a9uQ35x9++EEYGBiIv/76S2u8omP8e/fuFUKUb9sq2sPzpA0bNggA4vPPP9dq79atm1AoFFp/AwCEgYGBOH36dImmV9w5KlOnThVmZmbi3LlzWu2ffPKJMDQ0FFeuXBFC/N/7mr29vbh3755mvOjoaAFABAYGioKCAk17z549hVKp1FrXRXt2ntyDkpmZKZydnUW9evXKXJOlpaVIT0/XGrcittfS7lHRV0dJt3l9it7Tiub3SSEhIeK111575uufNGzYMGFoaKh3mL29vXjvvfdK3Fdl4lU/pdSmTRvs378fnTp1QmJiIr788ku0a9cOLi4u2LRpU7n6joiI0Pzf0NAQDRo0gBACAwYM0LRbW1vD29sbFy9efGZfmzdvBgCMGjVKq3306NEAgN9//73U9R07dgwpKSkYOXKkznF1hUIBAEhNTcXx48fRt29f2NraaoYHBASgTZs2mrrKonXr1vD09NTq09LS8rnLAoCm3o0bN0KtVpdquiYmJpr/Z2Zm4vbt2wgLC8PFixeRmZkJ4PGejvv37+OTTz7ROT+gaNkUUalU6Nevn1bb5s2b4eTkhJ49e2rajIyMMGLECGRnZ+PPP//UzMeDBw+wffv2Z87r6dOnkZycXKr5/OWXXxAYGKj3213RPBgaGmqOt6vVaty5cwePHj1CgwYNcPTo0edO486dO/jjjz/Qo0cP3L9/H7dv38bt27eRkZGBdu3aITk5GdevXwcAJCQkoHHjxlqXy9va2qJXr15afe7YsQP5+fkYOXIkDAz+7y1t4MCBsLS01NnW9S1/fX7++Wf4+vrCx8dHU+ft27fRsmVLAMCuXbsAlG/b0mfz5s0wNDTEiBEjtNpHjx4NIQS2bNmi1R4WFgY/P79yTfPnn3/G66+/DhsbG615bd26NQoLC7Fnzx6t8bt37w4rKyvN80aNGgEAPvjgA805FEXt+fn5mnVapFq1alrbmaWlJfr06YNjx44hLS2tTDW98847sLe312or7/ZaFk/XUZptXp+HDx8CgN49icbGxprhJfHw4cNiz5cpbV+ViUGlDEJCQrBu3TrcvXsXBw8eRHR0NO7fv49u3brh33//LXO/NWvW1HpuZWUFY2NjzSGMJ9vv3r37zL4uX74MAwMD1KpVS6vdyckJ1tbWuHz5cqnru3DhAgA885BXUb/e3t46w3x9fXH79m08ePCg1NMGdJcPANjY2Dx3WQCPD6uFhoYiIiICjo6OeO+99/DTTz+V6INl7969aN26NczMzGBtbQ17e3v873//AwBNUCnJsini4uKi82Zx+fJl1K5dW+uDFni8zIqGA8DQoUPh5eWF9u3bo3r16ujfvz8SEhK0XjNlyhTcu3cPXl5eqFu3LsaOHYsTJ048t64LFy6UqP7ly5cjICAAxsbGqFq1Kuzt7fH7779rlsWznD9/HkIIfPbZZ7C3t9d6TJw4EcD/nZR++fJlne0XgE5bcducUqmEh4eHzraub/nrk5ycjNOnT+vU6eXlpVVnebYtfS5fvoxq1arBwsJCq/3pbaGIu7t7mabzpOTkZCQkJOjMa+vWrQHoXiig770KAGrUqKG3/em/0Vq1aukE+KLleunSpTLVVNxyKM/2WhZP11GabV6foi9KeXl5OsNyc3O1vkg9j4mJCfLz8/UOK21flYnnqJSDUqlESEgIQkJC4OXlhX79+uHnn3/GxIkTdf4IixQWFhbbn6GhYYnaAEAIUaIai6tDDkq7jMqzLExMTLBnzx7s2rULv//+OxISErBmzRq0bNkS27ZtK7bvCxcuoFWrVvDx8cGsWbNQo0YNKJVKbN68GbNnzy7Th1F53gwcHBxw/PhxbN26FVu2bMGWLVsQFxeHPn36YPny5QCAZs2a4cKFC9i4cSO2bduGJUuWYPbs2Vi4cKHWXruyWLFiBfr27YsuXbpg7NixcHBwgKGhIWJiYjRh7VmKlteYMWPQrl07vePoCycVqaTLX61Wo27dupg1a5be4UUfymXdtipKRXy4qNVqtGnTBh9//LHe4UUhokhx81Te96vy1KRvOZR3ewUev0/pq7+496mn6yjvNu/s7Azg8d7qp4NgamoqGjZsWHzxevoqLCxEeno6HBwcNO35+fnIyMhAtWrVStxXZWJQqSBFJyelpqYCgOYSr6dvPFaWPRll4erqCrVajeTkZM03MQC4efMm7t27B1dX11L3WXTY5dSpU5pvNfqmCwBnz57VGXbmzBnY2dnBzMwMwONlpO/GbOVZRs8KZgYGBmjVqhVatWqFWbNmYfr06Rg/fjx27dpV7Pz8+uuvyMvLw6ZNm7S+RRbt9i/y5LIpywetq6srTpw4AbVarbVX5cyZM5rhRZRKJTp27IiOHTtCrVZj6NCh+O677/DZZ59ppm1ra4t+/fqhX79+yM7ORrNmzTBp0qRnBhVPT0+cOnXqmXWuXbsWHh4eWLdundayLvpmWKS49eDh4QHg8WGt4pZ5EVdXV5w/f16n/em2J7e5ov6Bx2++KSkpz51OcTw9PZGYmIhWrVo9N/CXZdsqjqurK3bs2IH79+9r7VXRty2UVnHz4enpiezs7DIvq9Iq2svwZD3nzp0DAM3JwBVRU3m3V+Dx+5S+w8slfZ8qzTavT9Ghz8OHD2uFkhs3buDatWsYNGhQmfp68803Ne2HDx+GWq2W7V3JeeinlHbt2qU3XRede1G0+9nS0hJ2dnY6x1EXLFjw4osENBvh02fGF3077NChQ6n7rF+/Ptzd3TFnzhydgFG0TJydnREUFITly5drjXPq1Cls27ZN64/D09MTmZmZWoclUlNTNVcklUVRCHq6vjt37uiMW/RHqW+XapGib4hPrvPMzEzExcVpjde2bVtYWFggJiYGubm5WsNK8m3yzTffRFpaGtasWaNpe/ToEebOnQtzc3OEhYUBeHzFypMMDAw0VycUzcfT45ibm6NWrVrPnE/g8bH1xMREvcu/aB70LY9//vkH+/fv1xq/6L4wT68HBwcHNG/eHN99950m1D/p1q1bmv+3a9cO+/fvx/HjxzVtd+7cwcqVK7Ve07p1ayiVSnz77bdadS1duhSZmZll2tYBoEePHrh+/ToWL16sM+zhw4eaQ5hl3baK8+abb6KwsBDz5s3Tap89ezYUCgXat29f6j6LmJmZ6f1y0KNHD+zfvx9bt27VGXbv3r0y3wG1ODdu3NDazrKysvD9998jKCgITk5OFVZTebdX4PH71JkzZ7S2zcTExBJdMQiUbpvXx9/fHz4+Pli0aJHWXpzY2FgoFAp069atRHUAQMuWLWFra4vY2Fit9tjYWJiampb5b+VF4x6VUoqMjEROTg66du0KHx8f5OfnY9++fVizZg3c3Ny0TtKLiIjAjBkzEBERgQYNGmDPnj2abw0vWmBgIMLDw7Fo0SLcu3cPYWFhOHjwIJYvX44uXbqgRYsWpe7TwMAAsbGx6NixI4KCgtCvXz84OzvjzJkzOH36tOYNZebMmWjfvj0aN26MAQMGaC5PtrKywqRJkzT9vffeexg3bhy6du2KESNGICcnB7GxsfDy8irziW7BwcEAgPHjx+O9996DkZEROnbsiClTpmDPnj3o0KEDXF1dkZ6ejgULFqB69epo2rRpsf21bdtWswfjww8/RHZ2NhYvXgwHBwetNx1LS0vMnj0bERERCAkJwfvvvw8bGxskJiYiJydHc1imOIMGDcJ3332Hvn374siRI3Bzc8PatWuxd+9ezJkzR/PNOiIiAnfu3EHLli1RvXp1XL58GXPnzkVQUJBmz5mfnx+aN2+O4OBg2Nra4vDhw1i7di2GDx/+zBrGjh2LtWvXonv37ujfvz+Cg4Nx584dbNq0CQsXLkRgYCDeeustrFu3Dl27dkWHDh2QkpKChQsXws/PD9nZ2Zq+TExM4OfnhzVr1sDLywu2traoU6cO6tSpg/nz56Np06aoW7cuBg4cCA8PD9y8eRP79+/HtWvXkJiYCAD4+OOPsWLFCrRp0waRkZGay5Nr1qyJO3fuaL4F29vbIzo6GpMnT8Ybb7yBTp064ezZs1iwYAFCQkLKfLll79698dNPP2Hw4MHYtWsXQkNDUVhYiDNnzuCnn37C1q1b0aBBgzJvW8Xp2LEjWrRogfHjx+PSpUsIDAzEtm3bsHHjRowcOVLrhPLSCg4ORmxsLD7//HPUqlULDg4OaNmyJcaOHYtNmzbhrbfeQt++fREcHIwHDx7g5MmTWLt2LS5duqRzrlx5eHl5YcCAATh06BAcHR2xbNky3Lx5U+sLQEXUVBHba//+/TFr1iy0a9cOAwYMQHp6OhYuXAh/f39kZWWVaH5Lus0XZ+bMmejUqRPatm2L9957D6dOncK8efMQERGhtcf8eUxMTDB16lQMGzYM3bt3R7t27fDXX39hxYoVmDZtmtYFELJS6dcZveS2bNki+vfvL3x8fIS5ubnmdvqRkZHi5s2bWuPm5OSIAQMGCCsrK2FhYSF69Ogh0tPTi708+enLG4u7bFjfJY36FBQUiMmTJwt3d3dhZGQkatSooXPDt2dNpzh///23aNOmjbCwsBBmZmYiICBA6xJhIYTYsWOHCA0NFSYmJsLS0lJ07NhR54ZvQjy+3LtOnTpCqVQKb29vsWLFimfe8O1prq6uOpdqT506Vbi4uAgDAwPNZaw7d+4UnTt3FtWqVRNKpVJUq1ZN9OzZU+fSR302bdokAgIChLGxsXBzcxNffPFFsTcd27Rpk2jSpIlmvhs2bChWr16tGf6sdXfz5k3Rr18/YWdnJ5RKpahbt67O5e1r164Vbdu2FQ4ODkKpVIqaNWuKDz/8UKSmpmrG+fzzz0XDhg2FtbW1MDExET4+PmLatGk6l9Drk5GRIYYPHy5cXFw0NzgLDw8Xt2/fFkI8vqRy+vTpwtXVVahUKlGvXj3x22+/6b3UfN++fSI4OFgolUqdbf7ChQuiT58+wsnJSRgZGQkXFxfx1ltvibVr12r1cezYMfH6668LlUolqlevLmJiYsS3334rAIi0tDStcefNmyd8fHyEkZGRcHR0FEOGDCn2hm/66LsMNT8/X3zxxRfC399fqFQqYWNjI4KDg8XkyZNFZmamEEKUa9sqrp779++Ljz76SFSrVk0YGRmJ2rVrP/OGbyWVlpYmOnToICwsLHRu+Hb//n0RHR0tatWqJZRKpbCzsxNNmjQRX331lWbbefKmZk/atWuXACB+/vlnrfa4uDgBQBw6dEjT9uQN3wICAoRKpRI+Pj46ry1vTUJU3Pa6YsUKzY0zg4KCxNatW595wzd9SrrNF2f9+vUiKChI87fw6aefluhvWp9FixYJb29vzU30Zs+erbNtyYlCiDKc5UREJJGRI0fiu+++Q3Z29gs/UZUqnpubG+rUqYPffvtN6lLoJcFzVIhItp6+r0NGRgZ++OEHNG3alCGF6BXBc1SISLYaN26M5s2bw9fXFzdv3sTSpUuRlZWFzz77TOrSiGQjPz9f70ndT7KyspLtfVKeh0GFiGTrzTffxNq1a7Fo0SIoFArUr18fS5cufe7vXBG9Svbt2/fcCyTi4uLQt2/fyimogvEcFSIiopfY3bt3ceTIkWeO4+/vr7l53MuGQYWIiIhkiyfTEhERkWy91OeoqNVq3LhxAxYWFrL+TRsiIiL6P0II3L9/H9WqVdP5MdanvdRB5caNGzo/0kREREQvh6tXr6J69erPHOelDipFtxW/evUqLC0tJa6GiIiISiIrKws1atTQ+uHN4rzUQaXocI+lpSWDChER0UumJKdt8GRaIiIiki0GFSIiIpItBhUiIiKSrZf6HBUiIvpvKCwsREFBgdRlUAUxMjKqsB8OZVAhIiLJCCGQlpaGe/fuSV0KVTBra2s4OTmV+z5nDCpERCSZopDi4OAAU1NT3rzzP0AIgZycHKSnpwNAuX9jiEGFiIgkUVhYqAkpVatWlbocqkAmJiYAgPT0dDg4OJTrMBBPpiUiIkkUnZNiamoqcSX0IhSt1/Kee8SgQkREkuLhnv+milqvDCpEREQkW5IGlUmTJkGhUGg9fHx8pCyJiIhIMpMmTYKjoyMUCgU2bNggdTkAgL59+6JLly6STV/yk2n9/f2xY8cOzfMqVSQviYiIJOb2ye+VNq1LMzqU+jV9+/bF8uXLATy+Z0jNmjXRp08f/O9//yvz51hSUhImT56M9evX47XXXoONjU2Z+vmvkTwVVKlSBU5OTlKXQUREVCpvvPEG4uLikJeXh82bN2PYsGEwMjJCdHS01nj5+flQKpXP7e/ChQsAgM6dO5fr/I6CggIYGRmVqQY5kvwcleTkZFSrVg0eHh7o1asXrly5InVJREREz6VSqeDk5ARXV1cMGTIErVu3xqZNmzSHSqZNm4Zq1arB29sbAHD16lX06NED1tbWsLW1RefOnXHp0iUAjw/5dOzYEQBgYGCgFVSWLFkCX19fGBsbw8fHBwsWLNAMu3TpEhQKBdasWYOwsDAYGxtj5cqVZaoBeHzJ+KhRo2BtbY2qVavi448/hhDiBS/JZ5M0qDRq1Ajx8fFISEhAbGwsUlJS8Prrr+P+/ft6x8/Ly0NWVpbWg4iISA5MTEyQn58PANi5cyfOnj2L7du347fffkNBQQHatWsHCwsL/PXXX9i7dy/Mzc3xxhtvID8/H2PGjEFcXBwAIDU1FampqQCAlStXYsKECZg2bRqSkpIwffp0fPbZZ5rDTkU++eQTREVFISkpCe3atStTDQDw9ddfIz4+HsuWLcPff/+NO3fuYP369ZW1CPWS9NBP+/btNf8PCAhAo0aN4Orqip9++gkDBgzQGT8mJgaTJ0+uzBKfqe7yulKXIImT4SelLkESXN+vFq7vV8vp26dLNf693Hu4n38fp2+fhhACB/YcQMLWBLwf8T7u3r4LlYkKo2aMAv7/0Zavl3yN3IJcfDTjIygUCqihxtiZY9G4VmPEb4xHaItQZBk8/vKdUSXj8b+3MxD9aTQ+mvQRvJt5Iwc58G7mjV6DemH2/Nlo0KEBrt+5DgB4N+JdzTg5yMG93HslqiEuLg7W1tbYvXs32rZtizlz5iA6Ohpvv/02AGDhwoXYunVrBSzhspP8HJUnWVtbw8vLC+fPn9c7PDo6GqNGjdI8z8rKQo0aNSqrPCIiIo0/t/2JENcQPHr0CEIt8Obbb2Lo2KGYNm4aavvVhpHy/84TOXv6LK6kXEFDt4ZafeTl5uHqpat6+895kIOrl65iwsgJmPjRRE17YWEhzC3Ntcb1D/LXeX1JajBQGCA3NxcXLlxAZmYmUlNT0ahRI83wKlWqoEGDBpIe/pFVUMnOzsaFCxfQu3dvvcNVKhVUKlUlV0VERKQrpGkIJnw5AUZKI9g72Wtd7fP03XZzHuTAL9APX8R+odOPjZ3+q3tyHuQAACbNmoSA+gFawwwMtc/c0Hd335LUUNu2NgDA3t5ebw1yIGlQGTNmDDp27AhXV1fcuHEDEydOhKGhIXr27CllWURERM9lamqKmh41SzSuX4AfEjYkwNbeFuYW5s9/AQA7Bzs4ODng2uVreKvbW+UptdgaatnV0hrH2dkZ//zzD5o1awYAePToEY4cOYL69euXe/plJenJtNeuXUPPnj3h7e2NHj16oGrVqjhw4ICskx0REVFpdXinA2xsbRDZOxJH9h/BtcvXcHDvQUyPno60G2nFvm7ox0Ox5JslWLFoBS5duIRz/57D+lXrsTx2ebGvKU0Nu3fvxogRI3Dt2jUAQFRUFGbMmIENGzbgzJkzGDp0KO7du1fW2a4Qku5R+fHHH6WcPBERUaUwMTXB8k3LMWvKLIzsNxIPsh/AwdkBr73+2jP3sHTr3Q0mpiaImxeHryd/DRNTE3j5euGDDz+okBqqu1RHq1atYGlpCQAYPXo0UlNTER4eDgMDA/Tv3x9du3ZFZmZmmee9vBRC6gukyyErKwtWVlbIzMzULOTKxKsCXi1c368Wru8XLzc3FykpKXB3d4exsXGlTVef0l7181/hb6d7Em5Fedb6Lc3nt+Q3fCMiIiIqDoMKERERyRaDChEREckWgwoRERHJFoMKERERyRaDChEREckWgwoRERHJFoMKERERyRaDChEREckWgwoREdF/QB37Oti5eafUZVQ4SX/rh4iISK9JVpU4rdL/js344eOxcc1GzXMrGyvUCaqDURNHwdvfuyKre+VxjwoREVEZNG3ZFLtP7cbuU7ux9JelMKxiiGG9hhU7fkFBQSVW99/BoEJERFQGSpUSdo52sHO0g09dH0SMiEDa9TTcuX0H169cRx37Otiyfgv6duqL+tXr4/e1v+PenXsYO2gsWtZtiQY1G6Brs67YvG6zVr99O/fF9Ojp+Hry12hSuwnC/MIw/8v5WuNcvnAZ4R3DUb96fXQK7YR9u/dV5qxXKh76ISIiKqec7Bz8uvZX1HSvCWtbazzMeQgAmPP5HIyZPAaf1/0cKpUKeXl58Av0w4DIATCzMMOe7XsQPTQaNdxqoG79//vF7k1rNqHPkD5YnbAaxw8fx6eRn6Jew3po0rwJ1Go1RvYbiar2VbEqYRWys7LxxadfSDXrLxyDChERURn8ue1PhLiGAAAe5jyEvaM95q+cDwOD/ztY8cGgD9DmrTZar+s3rJ/m/70G9sLeXXuRsDFBK6h4+Xlh6NihAABXT1esXroa/+z5B02aN8H+P/cjJTkF3/30HRycHAAAUeOjMPi9wS9sXqXEoEJERFQGIU1DMOHLCQCAzMxMrFm2BoN7DsaPW3/UjOMf5K/1msLCQiyesxhbN27FzdSbKMgvQEF+AUxMTLTG8/Lz0npu72iPjNsZAICL5y7CycVJE1IAIDAksELnTU4YVIiIiMrA1NQUNT1qap77zfHDax6vYe0Pa/HOB+9oxnlS3Lw4rFi0AuM+H4favrVhamqKGZ/O0DnRtoqR9sezQqGAUIsXNCfyxqBCRERUARQKBQwMDJCXm1fsOMcOHkOLN1qgY/eOAAC1Wo3LFy7D09uzxNPx8PJA2vU03Eq7BXsnewDAicMnyle8jDGoEBERlUF+Xj5u37wN4PGhn9VLViPnQQ7C2oUV+xpXD1ds+3Ubjh08BktrS3wf+z0ybmWUKqg0DmsMV09X/C/yfxg9cTQe3H+Ab6Z/U+75kSsGFSIiojL4+4+/0bxOcwCAmbkZ3Gu7Y9bSWWgY2hDXr1zX+5oPR32Ia5ev4cMeH8LY1Bjde3dHy/YtkX0/u8TTNTAwwDfLv8GEqAno2a4nXGq4IHp6ND5898OKmC3ZUQghXtqDXllZWbCyskJmZiYsLS0rffp1l9d9/kj/QSfDT0pdgiS4vl8tXN8vXm5uLlJSUuDu7g5jY+NKm64+p2+flnT6UvG383/+SGX0rPVbms9v3vCNiIiIZItBhYiIiGSLQYWIiIhki0GFiIiIZItBhYiIiGSLQYWIiIhki0GFiIiIZItBhYiIiGSLQYWIiIhki0GFiIjoJdO3c1/MGD+jXH3M/3I+goKCKqagF4i/9UNERLJTmT9hUNqfDRg/fDw2rtmIkZ+ORERUhKZ95+adiAqPwqlbp8pVT0F+AX747gf89stvuHLxCoxNjOHm6YZ3PngHb3V/C0ZGRuXqv0i/of0wddzUCunrRWJQISIiKiWVsQrL5i5D9/DusLK2qrB+C/ILMKjHIJw9fRaRn0SiXsN6MLMww4kjJxA/Px6+dX3hU9enQqZlam6KqlWrVkhfLxIP/RAREZXSa81eQ1WHqljyzZJnjrf91+3o3LQz6rnUQ9v6bRG/IP6Z4//w3Q84sv8Ilv6yFD0H9IRPXR/UcKuBDu90wKqtq1DTo6ZmXLVaja8nf40mtZsgzC8M87+cr9VX6rVURPaORIhrCBq5N8LoAaNxO/22Zri+Qz/Lli2Dv78/VCoVnJ2dMXz4cM2we/fuISIiAvb29rC0tETLli2RmJj4nCVVfgwqREREpWRoaIio8VFYtWQV0m6k6R3ndOJpjI4YjfZd22P9nvUYOnYo5s2Yhw2rNxTb72+//IbXmr0G3wBfnWFGRkYwNTPVPN+0ZhNMTE2wOmE1Rk0chYVfLcS+3fsAPA4xkb0jkXk3E/Gb4rF47WJcvXwVYwaOKXbasbGxGDZsGAYNGoSTJ09i06ZNqFWrlmZ49+7dkZ6eji1btuDIkSOoX78+WrVqhTt37jxvcZULD/0QERGVQesOreFTxwfzv5iPqd/onuvxfez3aNSsEQaPHgwAcPN0w4VzFxA3Pw5denbR2+eVi1cQ0iSkRNP38vPC0LFDAQCunq5YvXQ1/tnzD5o0b4IDew4gOSkZCUcS4OziDACImR+Dzk074+Sxk6hbT/ccoM8//xyjR49GVFSUpi0k5HEtf//9Nw4ePIj09HSoVCoAwFdffYUNGzZg7dq1GDRoUIlqLgvuUSEiIiqjjz77CJvWbMKFcxd0hl08dxH1GtbTaqvXsB4uX7yMwsJCvf0JIUo8bS8/L63n9o72yLidoZm2k4uTJqQAgKe3JyytLHHx3EWdvtLT03Hjxg20atVK77QSExORnZ2NqlWrwtzcXPNISUnBhQu6816RuEeFiIiojBo0aYAmLZrgm8+/Qef3Ope7P1dPV6Qkp5Ro3CpG2h/hCoUCQl3yoPMkExOTZw7Pzs6Gs7Mzdu/erTPM2tq6TNMsKe5RISIiKoePPvsIu7fuRuJh7RNLPbw8cOzgMa22YwePwc3TDYaGhnr76vB2BxzYcwBJJ5J0hhUUFCDnQU6JavLw8kDa9TSkXk/VtF04ewFZmVnw9PbUGd/CwgJubm7YuXOn3v7q16+PtLQ0VKlSBbVq1dJ62NnZlaimsmJQISIiKgcvPy906NYBKxev1GoPHxKOf/b8g4VfL8SlC5ew8ceNWL10NfoO7VtsX70/7I16DethwDsDsHrpapw5dQZXL11FwoYE9HqjF65cvFKimhqHNUZt39r4ZPAn+DfxX5w8ehLRw6LRoEkD1Amqo/c1kyZNwtdff41vv/0WycnJOHr0KObOnQsAaN26NRo3bowuXbpg27ZtuHTpEvbt24fx48fj8OHDJVtQZcRDP0REROU0fNxwJGxI0GrzC/TD10u+xrwv5mHh1wth72iPYeOGFXsiLQAoVUosXrsY3y/8Hj99/xO+mvQVjE2M4VHbA70G9kIt31rFvvZJCoUCc3+Yi+nR0xHeKRwGBgZo2rIpomOii31NeHg4cnNzMXv2bIwZMwZ2dnbo1q2bpr/Nmzdj/Pjx6NevH27dugUnJyc0a9YMjo6OJaqprBSiNGfuyExWVhasrKyQmZkJS0vLSp9+Zd45UU5KexfH/wqu71cL1/eLl5ubi5SUFLi7u8PY2LjSpqvP6dunJZ2+VPzt/F9Y389av6X5/OahHyIiIpItBhUiIiKSLQYVIiIiki0GFSIiIpItBhUiIpLUS3xNBz1DRa1XBhUiIpKEkZERACAnp2Q3MaOXS9F6LVrPZcX7qBARkSQMDQ1hbW2N9PR0AICpqSkUCoUktagL1JJMV2q5ubkV3qcQAjk5OUhPT4e1tXWxd+EtKQYVIiKSjJOTEwBowopU0rOlnb5Uqtx7cTHA2tpas37Lg0GFiIgko1Ao4OzsDAcHBxQUFEhWR9T6KMmmLaVNXTe9kH6NjIzKvSelCIMKERFJztDQsMI+2MoiNT/1+SP9B0l9R+CS4Mm0REREJFsMKkRERCRbDCpEREQkWwwqREREJFsMKkRERCRbDCpEREQkWwwqREREJFuyCSozZsyAQqHAyJEjpS6FiIiIZEIWQeXQoUP47rvvEBAQIHUpREREJCOSB5Xs7Gz06tULixcvho2NjdTlEBERkYxIHlSGDRuGDh06oHXr1s8dNy8vD1lZWVoPIiIi+u+S9Ld+fvzxRxw9ehSHDh0q0fgxMTGYPHnyC66KiAg4mXJF6hKoEt1PmiF1CVQMyfaoXL16FVFRUVi5cmWJfxQpOjoamZmZmsfVq1dfcJVEREQkJcn2qBw5cgTp6emoX7++pq2wsBB79uzBvHnzkJeXp/NLmiqVCiqVqrJLJSIiIolIFlRatWqFkydParX169cPPj4+GDdunKQ/901ERETyIFlQsbCwQJ06dbTazMzMULVqVZ12IiIiejVJftUPERERUXEkvernabt375a6BCIiIpIR7lEhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItliUCEiIiLZYlAhIiIi2WJQISIiItmSNKjExsYiICAAlpaWsLS0ROPGjbFlyxYpSyIiIiIZkTSoVK9eHTNmzMCRI0dw+PBhtGzZEp07d8bp06elLIuIiIhkooqUE+/YsaPW82nTpiE2NhYHDhyAv7+/RFURERGRXEgaVJ5UWFiIn3/+GQ8ePEDjxo2lLoeIiIhkQPKgcvLkSTRu3Bi5ubkwNzfH+vXr4efnp3fcvLw85OXlaZ5nZWVVVplEREQkAcmv+vH29sbx48fxzz//YMiQIQgPD8e///6rd9yYmBhYWVlpHjVq1KjkaomIiKgySR5UlEolatWqheDgYMTExCAwMBDffPON3nGjo6ORmZmpeVy9erWSqyUiIqLKJPmhn6ep1WqtwztPUqlUUKlUlVwRERERSUXSoBIdHY327dujZs2auH//PlatWoXdu3dj69atUpZFREREMiFpUElPT0efPn2QmpoKKysrBAQEYOvWrWjTpo2UZREREZFMSBpUli5dKuXkiYiISOYkP5mWiIiIqDgMKkRERCRbZQoqHh4eyMjI0Gm/d+8ePDw8yl0UEREREVDGoHLp0iUUFhbqtOfl5eH69evlLoqIiIgIKOXJtJs2bdL8f+vWrbCystI8LywsxM6dO+Hm5lZhxREREdGrrVRBpUuXLgAAhUKB8PBwrWFGRkZwc3PD119/XWHFERER0autVEFFrVYDANzd3XHo0CHY2dm9kKKIiIiIgDLeRyUlJaWi6yAiIiLSUeYbvu3cuRM7d+5Eenq6Zk9LkWXLlpW7MCIiIqIyBZXJkydjypQpaNCgAZydnaFQKCq6LiIiIqKyBZWFCxciPj4evXv3ruh6iIiIiDTKdB+V/Px8NGnSpKJrISIiItJSpqASERGBVatWVXQtRERERFrKdOgnNzcXixYtwo4dOxAQEAAjIyOt4bNmzaqQ4oiIiOjVVqagcuLECQQFBQEATp06pTWMJ9YSERFRRSlTUNm1a1dF10FERESko0znqBARERFVhjLtUWnRosUzD/H88ccfZS6IiIiIqEiZgkrR+SlFCgoKcPz4cZw6dUrnxwqJiIiIyqpMQWX27Nl62ydNmoTs7OxyFURERERUpELPUfnggw/4Oz9ERERUYSo0qOzfvx/GxsYV2SURERG9wsp06Oftt9/Wei6EQGpqKg4fPozPPvusQgojIiIiKlNQsbKy0npuYGAAb29vTJkyBW3btq2QwoiIiIjKFFTi4uIqug4iIiIiHWUKKkWOHDmCpKQkAIC/vz/q1atXIUURERERAWUMKunp6Xjvvfewe/duWFtbAwDu3buHFi1a4Mcff4S9vX1F1khERESvqDJd9RMZGYn79+/j9OnTuHPnDu7cuYNTp04hKysLI0aMqOgaiYiI6BVVpj0qCQkJ2LFjB3x9fTVtfn5+mD9/Pk+mJSIiogpTpj0qarUaRkZGOu1GRkZQq9XlLoqIiIgIKGNQadmyJaKionDjxg1N2/Xr1/HRRx+hVatWFVYcERERvdrKFFTmzZuHrKwsuLm5wdPTE56ennB3d0dWVhbmzp1b0TUSERHRK6pM56jUqFEDR48exY4dO3DmzBkAgK+vL1q3bl2hxREREdGrrVR7VP744w/4+fkhKysLCoUCbdq0QWRkJCIjIxESEgJ/f3/89ddfL6pWIiIiesWUKqjMmTMHAwcOhKWlpc4wKysrfPjhh5g1a1aFFUdERESvtlIFlcTERLzxxhvFDm/bti2OHDlS7qKIiIiIgFIGlZs3b+q9LLlIlSpVcOvWrXIXRURERASUMqi4uLjg1KlTxQ4/ceIEnJ2dy10UEREREVDKoPLmm2/is88+Q25urs6whw8fYuLEiXjrrbcqrDgiIiJ6tZXq8uRPP/0U69atg5eXF4YPHw5vb28AwJkzZzB//nwUFhZi/PjxL6RQIiIievWUKqg4Ojpi3759GDJkCKKjoyGEAAAoFAq0a9cO8+fPh6Oj4wsplIiIiF49pb7hm6urKzZv3oy7d+/i/PnzEEKgdu3asLGxeRH1ERER0SusTHemBQAbGxuEhIRUZC1EREREWsr0Wz9ERERElYFBhYiIiGSLQYWIiIhki0GFiIiIZItBhYiIiGSLQYWIiIhki0GFiIiIZItBhYiIiGSLQYWIiIhki0GFiIiIZItBhYiIiGSLQYWIiIhki0GFiIiIZItBhYiIiGSLQYWIiIhki0GFiIiIZItBhYiIiGRL0qASExODkJAQWFhYwMHBAV26dMHZs2elLImIiIhkRNKg8ueff2LYsGE4cOAAtm/fjoKCArRt2xYPHjyQsiwiIiKSiSpSTjwhIUHreXx8PBwcHHDkyBE0a9ZMoqqIiIhILiQNKk/LzMwEANja2uodnpeXh7y8PM3zrKysSqmLiIiIpCGboKJWqzFy5EiEhoaiTp06eseJiYnB5MmTK7kyosdOplyRugSqRG65q6QuQRKXpC6A6Cmyuepn2LBhOHXqFH788cdix4mOjkZmZqbmcfXq1UqskIiIiCqbLPaoDB8+HL/99hv27NmD6tWrFzueSqWCSqWqxMqIiIhISpIGFSEEIiMjsX79euzevRvu7u5SlkNEREQyI2lQGTZsGFatWoWNGzfCwsICaWlpAAArKyuYmJhIWRoRERHJgKTnqMTGxiIzMxPNmzeHs7Oz5rFmzRopyyIiIiKZkPzQDxEREVFxZHPVDxEREdHTGFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhItiQNKnv27EHHjh1RrVo1KBQKbNiwQcpyiIiISGYkDSoPHjxAYGAg5s+fL2UZREREJFNVpJx4+/bt0b59eylLICIiIhmTNKiUVl5eHvLy8jTPs7KyJKyGiIiIXrSXKqjExMRg8uTJUpehcTLlitQlEBER/ae9VFf9REdHIzMzU/O4evWq1CURERHRC/RS7VFRqVRQqVRSl0FERESV5KXao0JERESvFkn3qGRnZ+P8+fOa5ykpKTh+/DhsbW1Rs2ZNCSsjIiIiOZA0qBw+fBgtWrTQPB81ahQAIDw8HPHx8RJVRURERHIhaVBp3rw5hBBSlkBEREQyxnNUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2GFSIiIhIthhUiIiISLYYVIiIiEi2ZBFU5s+fDzc3NxgbG6NRo0Y4ePCg1CURERGRDEgeVNasWYNRo0Zh4sSJOHr0KAIDA9GuXTukp6dLXRoRERFJTPKgMmvWLAwcOBD9+vWDn58fFi5cCFNTUyxbtkzq0oiIiEhikgaV/Px8HDlyBK1bt9a0GRgYoHXr1ti/f7+ElREREZEcVJFy4rdv30ZhYSEcHR212h0dHXHmzBmd8fPy8pCXl6d5npmZCQDIysp6sYUWJ09IM12pSbW8pcb1/UpR5+VIXYIkJHs/lRjXtzTTFeL576uSBpXSiomJweTJk3Xaa9SoIUE1r7AZVlJXQJWJ6/uVYjVH6gqoMkm9vu/fvw8rq2e/x0gaVOzs7GBoaIibN29qtd+8eRNOTk4640dHR2PUqFGa52q1Gnfu3EHVqlWhUCheeL1ykZWVhRo1auDq1auwtLSUuhx6wbi+Xy1c36+WV3V9CyFw//59VKtW7bnjShpUlEolgoODsXPnTnTp0gXA4/Cxc+dODB8+XGd8lUoFlUql1WZtbV0JlcqTpaXlK7Vhv+q4vl8tXN+vlldxfT9vT0oRyQ/9jBo1CuHh4WjQoAEaNmyIOXPm4MGDB+jXr5/UpREREZHEJA8q7777Lm7duoUJEyYgLS0NQUFBSEhI0DnBloiIiF49kgcVABg+fLjeQz2kn0qlwsSJE3UOg9F/E9f3q4Xr+9XC9f18ClGSa4OIiIiIJCD5nWmJiIiIisOgQkRERLLFoEJERESyxaBCREREsiWLq37o2W7fvo1ly5Zh//79SEtLAwA4OTmhSZMm6Nu3L+zt7SWukIiI6MXgHhWZO3ToELy8vPDtt9/CysoKzZo1Q7NmzWBlZYVvv/0WPj4+OHz4sNRlElEZPXz4EH///Tf+/fdfnWG5ubn4/vvvJaiKXpSkpCTExcVpfnj3zJkzGDJkCPr3748//vhD4urkiZcny9xrr72GwMBALFy4UOf3jIQQGDx4ME6cOIH9+/dLVCFVtqtXr2LixIlYtmyZ1KVQOZ07dw5t27bFlStXoFAo0LRpU/z4449wdnYG8Ph3z6pVq4bCwkKJK6WKkJCQgM6dO8Pc3Bw5OTlYv349+vTpg8DAQKjVavz555/Ytm0bWrZsKXWpssI9KjKXmJiIjz76SO+PLioUCnz00Uc4fvx45RdGkrlz5w6WL18udRlUAcaNG4c6deogPT0dZ8+ehYWFBUJDQ3HlyhWpS6MXYMqUKRg7diwyMjIQFxeH999/HwMHDsT27duxc+dOjB07FjNmzJC6TNnhOSoy5+TkhIMHD8LHx0fv8IMHD/LnBv5jNm3a9MzhFy9erKRK6EXbt28fduzYATs7O9jZ2eHXX3/F0KFD8frrr2PXrl0wMzOTukSqQKdPn9YcyuvRowd69+6Nbt26aYb36tULcXFxUpUnWwwqMjdmzBgMGjQIR44cQatWrTSh5ObNm9i5cycWL16Mr776SuIqqSJ16dIFCoUCzzoqq28PG718Hj58iCpV/u9tWKFQIDY2FsOHD0dYWBhWrVolYXX0IhT97RoYGMDY2FjrF4QtLCyQmZkpVWmyxaAic8OGDYOdnR1mz56NBQsWaI5VGxoaIjg4GPHx8ejRo4fEVVJFcnZ2xoIFC9C5c2e9w48fP47g4OBKropehKKT4X19fbXa582bBwDo1KmTFGXRC+Lm5obk5GR4enoCAPbv34+aNWtqhl+5ckVzfhL9H56j8hJ49913ceDAAeTk5OD69eu4fv06cnJycODAAYaU/6Dg4GAcOXKk2OHP29tCL4+uXbti9erVeofNmzcPPXv25Lr+DxkyZIjWidF16tTR2qO2ZcsWnkirB6/6IZKZv/76Cw8ePMAbb7yhd/iDBw9w+PBhhIWFVXJlRESVj0GFiIiIZIuHfoiIiEi2GFSIiIhIthhUiIiISLYYVIioXBQKBTZs2CB1GUT0H8WgQiRzV69eRf/+/VGtWjUolUq4uroiKioKGRkZlVrHpEmTEBQUpNOempqK9u3bv/Dp5+fn48svv0RgYCBMTU1hZ2eH0NBQxMXFoaCgoER9XLp0CQqFgj87QfQS4Q3fiGTs4sWLaNy4Mby8vLB69Wq4u7vj9OnTGDt2LLZs2YIDBw7A1tZW0hqdnJxe+DTy8/PRrl07JCYmYurUqQgNDYWlpSUOHDiAr776CvXq1dMbouQuPz8fSqVS6jKI5E0QkWy98cYbonr16iInJ0erPTU1VZiamorBgwdr2gCI9evXa41nZWUl4uLiNM+vXLkiunfvLqysrISNjY3o1KmTSElJ0QzftWuXCAkJEaampsLKyko0adJEXLp0ScTFxQkAWo+ifp+e7okTJ0SLFi2EsbGxsLW1FQMHDhT379/XDA8PDxedO3cWM2fOFE5OTsLW1lYMHTpU5OfnF7scvvjiC2FgYCCOHj2qMyw/P19kZ2cLIYTYsmWLCA0NFVZWVsLW1lZ06NBBnD9/XmsZPfkICwvTDFu8eLHw8fERKpVKeHt7i/nz52tNZ+/evSIwMFCoVCoRHBws1q9fLwCIY8eOacbZvXu3CAkJEUqlUjg5OYlx48aJgoICzfCwsDAxbNgwERUVJapWrSqaN28u+vXrJzp06KAzT/b29mLJkiXFLhOiVwWDCpFMZWRkCIVCIaZPn653+MCBA4WNjY1Qq9VCiOcHlfz8fOHr6yv69+8vTpw4If7991/x/vvvC29vb5GXlycKCgqElZWVGDNmjDh//rz4999/RXx8vLh8+bLIyckRo0ePFv7+/iI1NVWkpqZqwtOT083OzhbOzs7i7bffFidPnhQ7d+4U7u7uIjw8XFNTeHi4sLS0FIMHDxZJSUni119/FaampmLRokXFLouAgADRtm3b5y6ztWvXil9++UUkJyeLY8eOiY4dO4q6deuKwsJCIYQQBw8eFADEjh07RGpqqsjIyBBCCLFixQrh7OwsfvnlF3Hx4kXxyy+/CFtbWxEfHy+EECIzM1PY2tqKDz74QJw+fVps3rxZeHl5aQWVa9euCVNTUzF06FCRlJQk1q9fL+zs7MTEiRM19YWFhQlzc3MxduxYcebMGXHmzBmxd+9eYWhoKG7cuKEZb926dcLMzEwr4BG9qhhUiGTqwIEDesNHkVmzZgkA4ubNm0KI5weVH374QXh7e2uCjRBC5OXlCRMTE7F161aRkZEhAIjdu3frnd7EiRNFYGCgTvuT0120aJGwsbHR7OEQQojff/9dGBgYiLS0NCHE46Di6uoqHj16pBmne/fu4t133y12WZiYmIgRI0YUO7w4t27dEgDEyZMnhRBCpKSk6OwFEUIIT09PsWrVKq22qVOnisaNGwshhIiNjRVVq1YVDx8+1AxfvHixVl//+9//dJbv/Pnzhbm5uSYohYWFiXr16unU6efnJ7744gvN844dO4q+ffuWen6J/ot4Mi2RzInn3Dy6pOc4JCYm4vz587CwsIC5uTnMzc1ha2uL3NxcXLhwAba2tujbty/atWuHjh074ptvvkFqamqpak1KSkJgYCDMzMw0baGhoVCr1Th79qymzd/fH4aGhprnzs7OSE9PL7bf5y2DIsnJyejZsyc8PDxgaWkJNzc3AI9/7K04Dx48wIULFzBgwADNcjE3N8fnn3+OCxcuAADOnj2LgIAAGBsba17XsGFDnXlv3Lix1i9bh4aGIjs7G9euXdO06ftByYiICMTFxQF4/MvoW7ZsQf/+/Us0z0T/dTyZlkimatWqBYVCgaSkJHTt2lVneFJSEuzt7WFtbQ1A/48VPnk1THZ2NoKDg7Fy5Uqdvuzt7QEAcXFxGDFiBBISErBmzRp8+umn2L59O1577bUKnDPAyMhI67lCoYBarS52fC8vL5w5c+a5/Xbs2BGurq5YvHgxqlWrBrVajTp16iA/P7/Y12RnZwMAFi9ejEaNGmkNezJMVZQnQ1yRPn364JNPPsH+/fuxb98+uLu74/XXX6/waRO9jLhHhUimqlatijZt2mDBggV4+PCh1rC0tDSsXLkSffv21bTZ29tr7QFJTk5GTk6O5nn9+vWRnJwMBwcH1KpVS+thZWWlGa9evXqIjo7Gvn37UKdOHaxatQrA4z03T/7yqz6+vr5ITEzEgwcPNG179+6FgYEBvL29y7QcAOD999/Hjh07cOzYMZ1hBQUFePDgATIyMnD27Fl8+umnaNWqFXx9fXH37l2tcYv2Pj05H46OjqhWrRouXryos1zc3d0BAN7e3jh58iTy8vI0rzt06JDOvO/fv18rLO7duxcWFhaoXr36M+evatWq6NKlC+Li4hAfH49+/fqVcMkQ/fcxqBDJ2Lx585CXl4d27dphz549uHr1KhISEtCmTRt4eXlhwoQJmnFbtmyJefPm4dixYzh8+DAGDx6steeiV69esLOzQ+fOnfHXX38hJSUFu3fvxogRI3Dt2jWkpKQgOjoa+/fvx+XLl7Ft2zYkJyfD19cXAODm5oaUlBQcP34ct2/f1vrQfnIaxsbGCA8Px6lTp7Br1y5ERkaid+/ecHR0LPNyGDlyJEJDQ9GqVSvMnz8fiYmJuHjxIn766Se89tprSE5Oho2NDapWrYpFixbh/Pnz+OOPPzBq1CitfhwcHGBiYoKEhATcvHkTmZmZAIDJkycjJiYG3377Lc6dO4eTJ08iLi4Os2bNAvA4KKnVagwaNAhJSUnYunUrvvrqKwDQHOoZOnQorl69isjISJw5cwYbN27ExIkTMWrUKBgYPP+tNiIiAsuXL0dSUhLCw8PLvKyI/nOkPUWGiJ4nJSVFhIeHC0dHR6FQKAQA8fbbb4sHDx5ojXf9+nXRtm1bYWZmJmrXri02b96sc3lyamqq6NOnj7CzsxMqlUp4eHiIgQMHiszMTJGWlia6dOkinJ2dhVKpFK6urmLChAmaE0Fzc3PFO++8I6ytrSvk8uQnRUVFaV0qrE9ubq6IiYkRdevW1fQdGhoq4uPjNZcAb9++Xfj6+gqVSiUCAgLE7t27depbvHixqFGjhjAwMNCa5sqVK0VQUJBQKpXCxsZGNGvWTKxbt04zfO/evSIgIEAolUoRHBwsVq1aJQCIM2fOaMYpyeXJUVFReudPrVYLV1dX8eabbz5zORC9ahRClPAsNSKShYkTJ2LWrFkv5NwRKrmVK1eiX79+yMzMhImJSbn7y87OhouLC+Li4vD2229XQIVE/w08mZboJTN58mS4ubnhwIEDaNiwYYkOK1D5ff/99/Dw8ICLiwsSExMxbtw49OjRo9whRa1W4/bt2/j6669hbW2NTp06VVDFRP8NDCpELyGebFn50tLSMGHCBKSlpcHZ2Rndu3fHtGnTyt3vlStX4O7ujurVqyM+Ph5VqvBtmehJPPRDREREssV9xkRERCRbDCpEREQkWwwqREREJFsMKkRERCRbDCpEREQkWwwqREREJFsMKkRERCRbDCpEREQkWwwqREREJFv/D9efe9FUbvlqAAAAAElFTkSuQmCC",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "unique_temperatures = no_stem_summary_df[\"Temperature\"].unique()\n",
    "\n",
    "for temp in unique_temperatures:\n",
    "    temp_df = no_stem_summary_df[no_stem_summary_df[\"Temperature\"] == temp]\n",
    "\n",
    "    temp_df.plot(kind=\"bar\", stacked=True)\n",
    "\n",
    "    plt.title(f\"Sum of counts across categories for temperature {temp}\")\n",
    "    plt.xlabel(\"Question Category\")\n",
    "    plt.ylabel(\"Count\")\n",
    "\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Brand vs Preferred\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for effective with temperature 0.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 5/5 [00:01<00:00,  4.06it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for safe with temperature 0.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 5/5 [00:01<00:00,  3.54it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for associated with side effects with temperature 0.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 5/5 [00:01<00:00,  2.62it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for likely to make me sick with temperature 0.0: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 5/5 [00:01<00:00,  3.80it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for effective with temperature 0.8: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 5/5 [00:01<00:00,  3.46it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for safe with temperature 0.8: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 5/5 [00:01<00:00,  3.39it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for associated with side effects with temperature 0.8: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 5/5 [00:01<00:00,  3.86it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Inference for likely to make me sick with temperature 0.8: 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 5/5 [00:02<00:00,  2.02it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first answer: 2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "dict_keys(['temp_0_0', 'temp_0_8'])"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "stem_df = perform_inference(\n",
    "    processed_df_with_stem,\n",
    "    question_categories,\n",
    "    temperatures,\n",
    "    get_chat_completion,\n",
    "    stem=True,\n",
    "    debug=True,\n",
    ")\n",
    "\n",
    "stem_df.keys()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "  Temperature             Question Category  Preferred  Brand  No Choice\n",
      "0         0_0                     effective          2      3          0\n",
      "1         0_0                          safe          3      2          0\n",
      "2         0_0  associated with side effects          1      4          0\n",
      "3         0_0        likely to make me sick          1      4          0\n",
      "4         0_8                     effective          2      3          0\n",
      "5         0_8                          safe          3      2          0\n",
      "6         0_8  associated with side effects          1      4          0\n",
      "7         0_8        likely to make me sick          1      4          0\n"
     ]
    }
   ],
   "source": [
    "stem_summary_df = summarize_choices(stem_df, question_categories, stem=True)\n",
    "print(stem_summary_df)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Plot\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['0_0' '0_8']\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "unique_temperatures = stem_summary_df[\"Temperature\"].unique()\n",
    "\n",
    "for temp in unique_temperatures:\n",
    "    temp_df = stem_summary_df[stem_summary_df[\"Temperature\"] == temp]\n",
    "\n",
    "    temp_df.plot(kind=\"bar\", stacked=True)\n",
    "\n",
    "    plt.title(f\"Sum of counts across categories for temperature {temp}\")\n",
    "    plt.xlabel(\"Question Category\")\n",
    "    plt.ylabel(\"Count\")\n",
    "\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Save\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Saved DataFrame to results/preference/temp_0_0_no_stem_df.csv\n",
      "Saved DataFrame to results/preference/temp_0_8_no_stem_df.csv\n",
      "Saved DataFrame to results/preference/no_stem_summary_df.csv\n"
     ]
    }
   ],
   "source": [
    "# Save the no_stem_dfs\n",
    "for temp_key, temp_df in no_stem_df.items():\n",
    "    # Save the temperature-specific DataFrame\n",
    "    temp_df_filename = os.path.join(output_dir, f\"{temp_key}_no_stem_df.csv\")\n",
    "    temp_df.to_csv(temp_df_filename, index=False)\n",
    "    print(f\"Saved DataFrame to {temp_df_filename}\")\n",
    "\n",
    "# Save the no_stem_summary_df\n",
    "no_stem_summary_df_filename = os.path.join(output_dir, \"no_stem_summary_df.csv\")\n",
    "no_stem_summary_df.to_csv(no_stem_summary_df_filename, index=False)\n",
    "print(f\"Saved DataFrame to {no_stem_summary_df_filename}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Saved DataFrame to results/preference/temp_0_0_stem_df.csv\n",
      "Saved DataFrame to results/preference/temp_0_8_stem_df.csv\n",
      "Saved DataFrame to results/preference/stem_summary_df.csv\n"
     ]
    }
   ],
   "source": [
    "# Save the stem_dfs\n",
    "for temp_key, temp_df in stem_df.items():\n",
    "    # Save the temperature-specific DataFrame\n",
    "    temp_df_filename = os.path.join(output_dir, f\"{temp_key}_stem_df.csv\")\n",
    "    temp_df.to_csv(temp_df_filename, index=False)\n",
    "    print(f\"Saved DataFrame to {temp_df_filename}\")\n",
    "\n",
    "# Save the stem_summary_df\n",
    "stem_summary_df_filename = os.path.join(output_dir, \"stem_summary_df.csv\")\n",
    "stem_summary_df.to_csv(stem_summary_df_filename, index=False)\n",
    "print(f\"Saved DataFrame to {stem_summary_df_filename}\")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "in_biased_learning",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
